Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Different Treatment Regimens in Patients With Stage 1-2 Type C Hepatic Encephalopathy: AST-120 vs Lactulose

NCT00558038 is registered in ClinicalTrials.gov with Ocera Therapeutics as lead sponsor.

NCT NCT00558038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00558038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Different Treatment Regimens in Patients With Stage 1-2 Type C Hepatic Encephalopathy: AST-120 vs Lactulose
Lead sponsor
Ocera Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2007
Completion date
June 30, 2009
Enrollment
40 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic encephalopathy